Integrated DNA Technologies, Inc. (IDT) is a prominent supplier to the pharmaceutical industry, specialising in the development, manufacture, and marketing of nucleic acid products for the life sciences sector. The company focuses on academic research, biotechnology, agriculture, medical diagnostics, and pharmaceutical development. IDT's core business lies in the production of custom oligonucleotides for a range of molecular biology applications. Through its innovative proprietary technologies, IDT supports genomics applications including next-generation sequencing, CRISPR genome editing, qPCR, and RNA interference. Additionally, IDT offers GMP services to produce products utilised in diagnostic tests for various cancers as well as inherited and infectious diseases.

Services include:
- Custom oligonucleotide synthesis
- qPCR primers
- Probe design and synthesis
- Gene synthesis
- Synthesis of RNA and other nucleic acids
- CRISPR guide RNA design and synthesis
- Next-generation sequencing
- GMP manufacturing services
- Custom sequencing services

Integrated DNA Technologies (IDT) continues to drive advancements in molecular biology and diagnostics, offering critical solutions to researchers and developers in the pharmaceutical field. For more information, visit idtdna.com.